Cavanagh Bethany J sold BEAM
October 1, 2026 · Form 4 insider transaction
Cavanagh Bethany J sold 187 shares of Beam Therapeutics Inc. at $24.41 per share, a transaction worth $4.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
187
Price
$24.41
Total value
$4.6K
InsiderCavanagh Bethany J
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 1, 2026
Filing dateOctober 2, 2026
Shares owned after50,984
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on September 30, 2024. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2024.